Combination of CALR and PDIA3 is a potential prognostic biomarker for non-small cell lung cancer

Proteomic-based approaches for biomarker discovery are promising strategies used in cancer research. In this study, we performed quantitative proteomic analysis on 16 paired samples of non-small cell lung cancer (NSCLC) and adjacent non-tumor lung tissues using label-free quantitative proteomics and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ke, Li, Hao, Chen, Ruo, Zhang, Yang, Sun, Xiu-Xuan, Huang, Wan, Bian, Huijie, Chen, Zhi-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722536/
https://www.ncbi.nlm.nih.gov/pubmed/29228584
http://dx.doi.org/10.18632/oncotarget.18547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722536/
https://www.ncbi.nlm.nih.gov/pubmed/29228584
http://dx.doi.org/10.18632/oncotarget.18547

Ejemplares similares